{"id":"W4366280595","doi":"10.1038/s41467-023-37648-w","title":"Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Nature Communications","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Deutsche Forschungsgemeinschaft; F. Hoffmann-La Roche","keywords":"Venetoclax; Obinutuzumab; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Internal medicine; Oncology; Minimal residual disease; Hazard ratio; Bendamustine; Clinical endpoint; Leukemia; Gastroenterology; Randomized controlled trial; Chemotherapy; Confidence interval; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001906685,0.0003675405,0.001176277,0.0003558642,0.0003227537,0.00006518832,0.001633454,0.0005191368,0.00002491269],"category_scores_gemma":[0.002472861,0.0002744209,0.000218736,0.001668872,0.0009104451,0.0001324522,0.0007586278,0.001829626,0.00005787653],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.3371395,"about_ca_system_score_gemma":0.1219113,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03408729,"about_ca_topic_score_gemma":0.01756868,"domain_scores_codex":[0.9958215,0.0009832716,0.001104789,0.0006385724,0.0008713948,0.0005804576],"domain_scores_gemma":[0.9888406,0.006508426,0.0002870407,0.003937536,0.0002618257,0.0001646013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7392485,0.0002030648,0.000200145,0.0008002914,0.004336522,0.0003330239,0.09851328,0.1220588,0.004170598,0.006287256,0.02104768,0.002800872],"study_design_scores_gemma":[0.540374,0.0003627439,0.0009119394,0.0003549791,0.0003564395,0.00001509503,0.005342075,0.4501221,0.0002353644,0.00009256524,0.001612911,0.0002197231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981958,0.01091929,0.000002230267,0.0005398322,0.000299581,0.004613495,0.0001914181,0.0001912222,0.001284986],"genre_scores_gemma":[0.9927045,0.005138087,0.0002189459,0.00007791197,0.0001492646,0.0006594241,0.0005695081,0.00006936432,0.0004129829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3280633,"threshold_uncertainty_score":0.9999708,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04807670329651975,"score_gpt":0.3432482560445208,"score_spread":0.2951715527480011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}